Pn a month of political whiplash for Brazil’s battle over medical marijuana access, public outcry has delayed regulators’ bid to reinstate prohibition for almost all eligible patients.
An October 11 resolution by the Federal Council of Medicine (CFM), the agency with which Brazilian providers must remain in good standing or risk their license being revoked, limited CBD prescriptions to only a small handful of medical conditions and banned THC for all conditions—including cancer, Alzheimer’s, chronic pain or multiple sclerosis. Doctors were also banned from lecturing on the subject in academic settings.
“Patients who won the right to receive medication from the state, through the courts, [feared] having these legal decisions suspended,” Monique Prado, a parliamentary assistant in drug policy at the Legislative Assembly of Rio de Janeiro, told Filter. “And that their clinical situation would worsen.”
Full article at Filter Mag’s website. Date of publication: 01/12/2022.